JP2020007330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020007330A5 JP2020007330A5 JP2019151759A JP2019151759A JP2020007330A5 JP 2020007330 A5 JP2020007330 A5 JP 2020007330A5 JP 2019151759 A JP2019151759 A JP 2019151759A JP 2019151759 A JP2019151759 A JP 2019151759A JP 2020007330 A5 JP2020007330 A5 JP 2020007330A5
- Authority
- JP
- Japan
- Prior art keywords
- protein transduction
- transduction reagent
- reagent modified
- modified
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361895562P | 2013-10-25 | 2013-10-25 | |
| US61/895,562 | 2013-10-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018187189A Division JP6577112B2 (ja) | 2013-10-25 | 2018-10-02 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020007330A JP2020007330A (ja) | 2020-01-16 |
| JP2020007330A5 true JP2020007330A5 (https=) | 2020-06-25 |
| JP6880125B2 JP6880125B2 (ja) | 2021-06-02 |
Family
ID=52993686
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550686A Active JP6415582B2 (ja) | 2013-10-25 | 2014-10-27 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
| JP2018187189A Active JP6577112B2 (ja) | 2013-10-25 | 2018-10-02 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
| JP2019151759A Active JP6880125B2 (ja) | 2013-10-25 | 2019-08-22 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550686A Active JP6415582B2 (ja) | 2013-10-25 | 2014-10-27 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
| JP2018187189A Active JP6577112B2 (ja) | 2013-10-25 | 2018-10-02 | タンパク質誘導生体内細胞リプログラミングによる細胞転換に関する方法、システム、及び組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10076574B2 (https=) |
| EP (2) | EP3954381A1 (https=) |
| JP (3) | JP6415582B2 (https=) |
| KR (2) | KR102113829B1 (https=) |
| CN (2) | CN106170295B (https=) |
| AU (3) | AU2014339843B2 (https=) |
| CA (3) | CA2934065C (https=) |
| DK (1) | DK3060237T3 (https=) |
| ES (1) | ES2896021T3 (https=) |
| IL (3) | IL245300B (https=) |
| PL (1) | PL3060237T3 (https=) |
| PT (1) | PT3060237T (https=) |
| SG (1) | SG11201603230UA (https=) |
| WO (1) | WO2015061779A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| WO2015105955A1 (en) | 2014-01-08 | 2015-07-16 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| JP6530206B2 (ja) * | 2015-03-17 | 2019-06-12 | 学校法人同志社 | 上皮間葉転換阻害剤及び癌転移治療剤 |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| CN106110297B (zh) * | 2016-07-05 | 2019-12-17 | 南通大学 | Gfi1截短体的应用 |
| CN110536685A (zh) | 2016-12-23 | 2019-12-03 | 昆士兰大学 | Sox18蛋白活性的抑制剂用于治疗血管生成相关疾病和/或淋巴管生成相关疾病 |
| JP2018132365A (ja) * | 2017-02-14 | 2018-08-23 | 株式会社神戸製鋼所 | マーキング装置 |
| EP3717505A4 (en) | 2017-12-01 | 2021-12-01 | Encoded Therapeutics, Inc. | GENENICALLY MODIFIED DNA-BINDING PROTEINS |
| KR102439221B1 (ko) | 2017-12-14 | 2022-09-01 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| US11340226B2 (en) * | 2018-03-02 | 2022-05-24 | The Chinese University Of Hong Kong | Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases |
| US11001618B2 (en) | 2018-03-02 | 2021-05-11 | Northwestern University | Overexpression of FOXC1 to treat corneal vascularization |
| WO2019187918A1 (ja) * | 2018-03-29 | 2019-10-03 | 国立大学法人 琉球大学 | 分化コントロール化合物を用いて造腫瘍性をもつおそれのある未分化ｉＰＳ細胞等の混入を除去する方法 |
| IL281470B2 (en) | 2018-09-28 | 2025-08-01 | Harvard College | Cellular reprogramming to reverse aging and promote organ and tissue regeneration |
| US12274733B2 (en) | 2018-09-28 | 2025-04-15 | President And Fellows Of Harvard College | Cellular reprogramming to reverse aging and promote organ and tissue regeneration |
| EP3942018A4 (en) * | 2019-03-17 | 2022-12-07 | Baylor College of Medicine | Direct reprogramming of cardiac fibroblasts into cardiomyocytes using an endothelial cell transdifferentiation strategy |
| US20220152224A1 (en) * | 2019-03-26 | 2022-05-19 | The Penn State Research Foundation | Methods and materials for treating cancer |
| KR102150489B1 (ko) * | 2019-04-09 | 2020-09-01 | 고려대학교 산학협력단 | 소변세포로부터 신장전구세포로의 직접 역분화를 유도하는 방법 및 이의 방법으로 역분화된 신장전구세포를 포함하는 신장세포 손상 질환 예방 또는 치료용 약학 조성물 |
| PL3976798T3 (pl) | 2019-05-29 | 2026-04-07 | Encoded Therapeutics, Inc. | Kompozycje i sposoby selektywnej regulacji genów |
| CA3157518A1 (en) * | 2019-10-17 | 2021-04-22 | Gong Chen | Regenerating functional neurons for treatment of neurological disorders |
| AU2020366448A1 (en) * | 2019-10-17 | 2022-05-12 | The Penn State Research Foundation | Regenerating functional neurons for treatment of hemorrhagic stroke |
| CN114364436A (zh) * | 2019-10-17 | 2022-04-15 | 宾州研究基金会 | 再生功能神经元以用于治疗脊髓损伤和als |
| AU2020391479A1 (en) * | 2019-11-25 | 2022-06-16 | The Penn State Research Foundation | Brain repair after traumatic brain injury through NeuroDl-mediated astrocyte-to-neuron conversion |
| CN112877364B (zh) * | 2019-11-29 | 2023-07-28 | 中国医学科学院药物研究所 | 软骨下骨细胞向关节软骨细胞直接转化的重编程诱导方案 |
| JPWO2021149823A1 (https=) * | 2020-01-24 | 2021-07-29 | ||
| CN111214660B (zh) * | 2020-02-25 | 2022-01-18 | 北京大学第三医院（北京大学第三临床医学院） | Pax4基因表达抑制剂在制备抑制纤维化的药物中的应用 |
| US11091524B1 (en) | 2020-04-22 | 2021-08-17 | Houston Gene Therapeutics Llc | Compositions for treatment of vascular disease |
| CN114231489A (zh) * | 2020-09-08 | 2022-03-25 | 纽伦捷生物医药科技（苏州）有限公司 | 用于重编程的功能性片段、组合及其应用 |
| JP2023543360A (ja) * | 2020-09-29 | 2023-10-13 | ニューエクセル・セラピューティクス・インコーポレイテッド | Ｄｌｘ２ベクター |
| WO2022072325A1 (en) * | 2020-09-29 | 2022-04-07 | NeuExcell Therapeutics Inc. | Neurod1 combination vector |
| CA3197316A1 (en) * | 2020-09-29 | 2022-04-07 | NeuExcell Therapeutics Inc. | Neurod1 and dlx2 vector |
| JP2022104813A (ja) | 2020-12-29 | 2022-07-11 | アイ ピース，インコーポレイテッド | リプログラミング因子を導入された細胞の培養方法 |
| CN113563428B (zh) * | 2021-06-22 | 2022-08-02 | 呈诺再生医学科技(珠海横琴新区)有限公司 | 特定空间结构多肽及其在制备iPSC中的应用 |
| CN117070477A (zh) * | 2022-05-10 | 2023-11-17 | 纽伦捷生物医药科技（上海）有限公司 | 重组溶瘤病毒的重编程的功能性片段、组合及其应用 |
| KR102902484B1 (ko) * | 2022-11-25 | 2025-12-22 | 고려대학교 산학협력단 | 방사선 치료에 의하여 손상된 근육 재생을 위한 고기능성 세포 치료제 조성물 |
| US12252518B2 (en) | 2023-01-06 | 2025-03-18 | Life Biosciences, Inc. | Methods of treating non-arteritic anterior ischemic optic neuropathy |
| WO2025106947A1 (en) * | 2023-11-17 | 2025-05-22 | Exir, Inc. | Compositions and methods for induced stem cell differentiation to neuronal lineage |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| EP0671926B1 (en) | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
| FR2766195A1 (fr) | 1997-07-21 | 1999-01-22 | Transgene Sa | Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique |
| DE19839491A1 (de) | 1998-08-29 | 2000-03-02 | Hermann Heumann | Verfahren zur Markierung von Biopolymeren mit Isotopen |
| US20040142474A1 (en) | 2000-09-14 | 2004-07-22 | Expression Genetics, Inc. | Novel cationic lipopolymer as a biocompatible gene delivery agent |
| US6696038B1 (en) | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
| DE60230147D1 (de) | 2001-07-06 | 2009-01-15 | Merck Patent Gmbh | Verfahren zur überwachung und modulierung von proteinfaltung |
| AU2002338947B2 (en) | 2001-11-30 | 2007-09-13 | Laboratoires Serono Sa | Methods of increasing protein expression levels |
| US20030134352A1 (en) | 2002-01-04 | 2003-07-17 | Freimuth Paul I. | Facilitating protein folding and solubility by use of peptide extensions |
| CA2471178A1 (en) | 2002-01-07 | 2003-07-17 | European Molecular Biology Laboratory | Recombinant protein expression |
| WO2005026196A2 (en) | 2003-09-12 | 2005-03-24 | Novexin Limited | Methods for folding proteins and reducing protein aggregation |
| EP1701737B1 (en) | 2003-11-25 | 2010-01-13 | THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY | Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| JP2010507645A (ja) | 2006-10-25 | 2010-03-11 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 前立腺癌を検出するための造影剤 |
| MX2010010165A (es) | 2008-03-17 | 2010-11-25 | Scripps Research Inst | Procedimientos quimicos y geneticos combinados para generacion de celulas madre pluripotentes inducidas. |
| US8722348B2 (en) | 2008-05-28 | 2014-05-13 | Wayne State University | Method and composition for a protein transduction technology and its applications |
| EP2641911A3 (en) * | 2008-12-23 | 2014-01-01 | Vivoscript, Inc. | Compositions and methods for re-programming cells without genetic modification |
| US20120128655A1 (en) | 2009-04-03 | 2012-05-24 | The Mclean Hospital Corporation | Induced pluripotent stem cells |
| US20120115225A1 (en) | 2009-04-23 | 2012-05-10 | Xu C W | Reprogramming of somatic cells with purified proteins |
| EP2253700A1 (en) | 2009-05-13 | 2010-11-24 | Helmholtz-Zentrum für Infektionsforschung GmbH | A method for producing test systems from donors suffering from adverse effects of medicaments and /or medical treatments, and uses of said systems |
| JP2013510563A (ja) | 2009-11-13 | 2013-03-28 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 操作された微小胞を用いた真核細胞のリプログラミング |
| JP2011135864A (ja) * | 2009-12-30 | 2011-07-14 | Korea Univ Research & Business Foundation | Ｏｃｔ４及びＢｍｉ１、またはその上位調節子を用いて体細胞から胚幹細胞類似細胞への逆分化を誘導する組成物及びこれを用いた胚幹細胞類似細胞の製造方法 |
| US20120301446A1 (en) | 2010-02-04 | 2012-11-29 | Vivoscript, Inc. | Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
| CA2807226A1 (en) * | 2010-08-19 | 2012-02-23 | F.Hoffmann-La Roche Ag | Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs) |
| AU2012220702B2 (en) * | 2011-02-22 | 2016-12-15 | The Board Of Regents Of The University Of Texas System | Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| PL2705143T3 (pl) * | 2011-05-02 | 2021-07-19 | Wayne State University | Technologia indukowanych białkiem komórek pluripotencjalnych, jej zastosowania |
| EP2734622B1 (en) * | 2011-07-19 | 2018-09-05 | Vivoscript, Inc. | Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| US9828585B2 (en) * | 2011-08-30 | 2017-11-28 | The J. David Gladstone Instututes | Methods for generating cardiomyocytes |
| US20180223260A1 (en) * | 2011-10-21 | 2018-08-09 | Stemgenics, Inc. | Functionalized nanoparticles for the intracellular delivery of biologically active molecules and methods for their manufacture and use |
-
2014
- 2014-10-27 CA CA2934065A patent/CA2934065C/en active Active
- 2014-10-27 PL PL14855040T patent/PL3060237T3/pl unknown
- 2014-10-27 KR KR1020167013867A patent/KR102113829B1/ko active Active
- 2014-10-27 EP EP21187708.9A patent/EP3954381A1/en not_active Withdrawn
- 2014-10-27 CA CA3194454A patent/CA3194454C/en active Active
- 2014-10-27 CA CA3291355A patent/CA3291355A1/en active Pending
- 2014-10-27 EP EP14855040.3A patent/EP3060237B1/en active Active
- 2014-10-27 KR KR1020207014071A patent/KR20200057108A/ko not_active Ceased
- 2014-10-27 AU AU2014339843A patent/AU2014339843B2/en active Active
- 2014-10-27 CN CN201480071293.0A patent/CN106170295B/zh active Active
- 2014-10-27 DK DK14855040.3T patent/DK3060237T3/da active
- 2014-10-27 WO PCT/US2014/062400 patent/WO2015061779A1/en not_active Ceased
- 2014-10-27 US US15/031,839 patent/US10076574B2/en active Active
- 2014-10-27 ES ES14855040T patent/ES2896021T3/es active Active
- 2014-10-27 SG SG11201603230UA patent/SG11201603230UA/en unknown
- 2014-10-27 CN CN202011127974.8A patent/CN112245592A/zh active Pending
- 2014-10-27 JP JP2016550686A patent/JP6415582B2/ja active Active
- 2014-10-27 PT PT148550403T patent/PT3060237T/pt unknown
-
2016
- 2016-04-25 IL IL245300A patent/IL245300B/en active IP Right Grant
-
2018
- 2018-09-04 US US16/120,829 patent/US10548983B2/en active Active
- 2018-10-02 JP JP2018187189A patent/JP6577112B2/ja active Active
-
2019
- 2019-05-19 IL IL266705A patent/IL266705B/en active IP Right Grant
- 2019-06-28 AU AU2019204630A patent/AU2019204630C1/en active Active
- 2019-08-22 JP JP2019151759A patent/JP6880125B2/ja active Active
-
2020
- 2020-01-28 IL IL272324A patent/IL272324B/en unknown
-
2021
- 2021-06-29 AU AU2021204485A patent/AU2021204485B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020007330A5 (https=) | ||
| JP2017503849A5 (https=) | ||
| Torreggiani et al. | Multimodal transfer of MDR by exosomes in human osteosarcoma | |
| Rizzi et al. | NGF steers microglia toward a neuroprotective phenotype | |
| MX2018002099A (es) | Compuestos y métodos para la administración transmembranal de moléculas. | |
| Luo et al. | Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia | |
| Orange et al. | Coley’s lessons remembered: augmenting mistletoe therapy | |
| Matsuura et al. | Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1 | |
| Man et al. | The HMGB1 signaling pathway activates the inflammatory response in Schwann cells | |
| Lee et al. | Muramyl dipeptide activates human beta defensin 2 and pro-inflammatory mediators through Toll-like receptors and NLRP3 inflammasomes in human dental pulp cells | |
| EP3423056A1 (en) | Methods for controlled proliferation of stem cells / generating inner ear hair cells using gsk-3-alpha inhibitors | |
| BR112015011729A2 (pt) | dispositivo de perfusão adesivo de vários dias para administração transdérmica de rotigotina | |
| Hwang et al. | WNT3A promotes myogenesis of human embryonic stem cells and enhances in vivo engraftment | |
| Han et al. | Activation of β-catenin signaling is critical for doxorubicin-induced epithelial–mesenchymal transition in BGC-823 gastric cancer cell line | |
| BR112022002116A2 (pt) | Filme, método de tratamento de uma doença ou condição, uso de um filme e método de fabricação de um filme | |
| Gerhart et al. | Antibody-conjugated, DNA-based nanocarriers intercalated with doxorubicin eliminate myofibroblasts in explants of human lens tissue | |
| CN105396130A (zh) | 皮氨钙佐剂及含有皮氨钙佐剂的疫苗 | |
| JP2025512536A (ja) | 免疫細胞若返りのための方法及び組成物並びに若返った免疫細胞を使用する療法 | |
| Herberman et al. | Interferon and NK cells | |
| Sandonà et al. | Amniotic membrane-derived stromal cells release extracellular vesicles that favor regeneration of dystrophic skeletal muscles | |
| Guo et al. | Growth and Turning Properties of Adult Glial Cell–Derived Neurotrophic Factor Coreceptor α1 Nonpeptidergic Sensory Neurons | |
| Kim et al. | Oligodendrocyte precursor cells stop sensory axons regenerating into the spinal cord | |
| CN105101951B (zh) | 一种用于基因-药物治疗的新型试剂 | |
| Albareda et al. | A randomized vehicle-controlled trial to assess the efficacy, safety, and tolerability of ozenoxacin 1% cream in 412 patients 2 months and older with impetigo | |
| Mentucci et al. | Implementing Photodynamic Therapy to Activate the IFN-1 Pathway in Melanoma Cells: A Protocol for Inducing Immunogenic Cell Death and Enhancing Dendritic Cell Maturation |